FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3099857122> ?p ?o ?g. }

• W3099857122 endingPage "28921" @default.
• W3099857122 startingPage "28918" @default.
• W3099857122 abstract "REV1/POLζ-dependent mutagenic translesion synthesis (TLS) promotes cell survival after DNA damage but is responsible for most of the resulting mutations. A novel inhibitor of this pathway, JH-RE-06, promotes cisplatin efficacy in cancer cells and mouse xenograft models, but the mechanism underlying this combinatorial effect is not known. We report that, unexpectedly, in two different mouse xenograft models and four human and mouse cell lines we examined in vitro cisplatin/JH-RE-06 treatment does not increase apoptosis. Rather, it increases hallmarks of senescence such as senescence-associated β-galactosidase, increased p21 expression, micronuclei formation, reduced Lamin B1, and increased expression of the immune regulators IL6 and IL8 followed by cell death. Moreover, although p-γ-H2AX foci formation was elevated and ATR expression was low in single agent cisplatin-treated cells, the opposite was true in cells treated with cisplatin/JH-RE-06. These observations suggest that targeting REV1 with JH-RE-06 profoundly affects the nature of the persistent genomic damage after cisplatin treatment and also the resulting physiological responses. These data highlight the potential of REV1/POLζ inhibitors to alter the biological response to DNA-damaging chemotherapy and enhance the efficacy of chemotherapy." @default.
• W3099857122 created "2020-11-23" @default.
• W3099857122 creator A5003416661 @default.
• W3099857122 creator A5004868995 @default.
• W3099857122 creator A5006842434 @default.
• W3099857122 creator A5008117998 @default.
• W3099857122 creator A5009113067 @default.
• W3099857122 creator A5014860176 @default.
• W3099857122 creator A5016607961 @default.
• W3099857122 creator A5050876541 @default.
• W3099857122 creator A5054824999 @default.
• W3099857122 creator A5081471690 @default.
• W3099857122 creator A5089833949 @default.
• W3099857122 creator A5090953868 @default.
• W3099857122 date "2020-11-09" @default.
• W3099857122 modified "2023-10-05" @default.
• W3099857122 title "REV1 inhibitor JH-RE-06 enhances tumor cell response to chemotherapy by triggering senescence hallmarks" @default.
• W3099857122 cites W1553978925 @default.
• W3099857122 cites W1974693247 @default.
• W3099857122 cites W2012012836 @default.
• W3099857122 cites W2042970469 @default.
• W3099857122 cites W2051857414 @default.
• W3099857122 cites W2064328955 @default.
• W3099857122 cites W2119974386 @default.
• W3099857122 cites W2145578278 @default.
• W3099857122 cites W2161687028 @default.
• W3099857122 cites W2619596151 @default.
• W3099857122 cites W2747521922 @default.
• W3099857122 cites W2757395631 @default.
• W3099857122 cites W2788548733 @default.
• W3099857122 cites W2899094752 @default.
• W3099857122 cites W2915058673 @default.
• W3099857122 cites W2948035094 @default.
• W3099857122 cites W2988310131 @default.
• W3099857122 cites W2988855986 @default.
• W3099857122 cites W3048927005 @default.
• W3099857122 cites W3095757372 @default.
• W3099857122 doi "https://doi.org/10.1073/pnas.2016064117" @default.
• W3099857122 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7682577" @default.
• W3099857122 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33168727" @default.
• W3099857122 hasPublicationYear "2020" @default.
• W3099857122 type Work @default.
• W3099857122 sameAs 3099857122 @default.
• W3099857122 citedByCount "23" @default.
• W3099857122 countsByYear W30998571222020 @default.
• W3099857122 countsByYear W30998571222021 @default.
• W3099857122 countsByYear W30998571222022 @default.
• W3099857122 countsByYear W30998571222023 @default.
• W3099857122 crossrefType "journal-article" @default.
• W3099857122 hasAuthorship W3099857122A5003416661 @default.
• W3099857122 hasAuthorship W3099857122A5004868995 @default.
• W3099857122 hasAuthorship W3099857122A5006842434 @default.
• W3099857122 hasAuthorship W3099857122A5008117998 @default.
• W3099857122 hasAuthorship W3099857122A5009113067 @default.
• W3099857122 hasAuthorship W3099857122A5014860176 @default.
• W3099857122 hasAuthorship W3099857122A5016607961 @default.
• W3099857122 hasAuthorship W3099857122A5050876541 @default.
• W3099857122 hasAuthorship W3099857122A5054824999 @default.
• W3099857122 hasAuthorship W3099857122A5081471690 @default.
• W3099857122 hasAuthorship W3099857122A5089833949 @default.
• W3099857122 hasAuthorship W3099857122A5090953868 @default.
• W3099857122 hasBestOaLocation W30998571222 @default.
• W3099857122 hasConcept C143425029 @default.
• W3099857122 hasConcept C153911025 @default.
• W3099857122 hasConcept C179093185 @default.
• W3099857122 hasConcept C190283241 @default.
• W3099857122 hasConcept C203014093 @default.
• W3099857122 hasConcept C2776694085 @default.
• W3099857122 hasConcept C2778239845 @default.
• W3099857122 hasConcept C2780723820 @default.
• W3099857122 hasConcept C502942594 @default.
• W3099857122 hasConcept C522857546 @default.
• W3099857122 hasConcept C54355233 @default.
• W3099857122 hasConcept C552990157 @default.
• W3099857122 hasConcept C86803240 @default.
• W3099857122 hasConcept C95444343 @default.
• W3099857122 hasConceptScore W3099857122C143425029 @default.
• W3099857122 hasConceptScore W3099857122C153911025 @default.
• W3099857122 hasConceptScore W3099857122C179093185 @default.
• W3099857122 hasConceptScore W3099857122C190283241 @default.
• W3099857122 hasConceptScore W3099857122C203014093 @default.
• W3099857122 hasConceptScore W3099857122C2776694085 @default.
• W3099857122 hasConceptScore W3099857122C2778239845 @default.
• W3099857122 hasConceptScore W3099857122C2780723820 @default.
• W3099857122 hasConceptScore W3099857122C502942594 @default.
• W3099857122 hasConceptScore W3099857122C522857546 @default.
• W3099857122 hasConceptScore W3099857122C54355233 @default.
• W3099857122 hasConceptScore W3099857122C552990157 @default.
• W3099857122 hasConceptScore W3099857122C86803240 @default.
• W3099857122 hasConceptScore W3099857122C95444343 @default.
• W3099857122 hasFunder F4320306082 @default.
• W3099857122 hasFunder F4320306271 @default.
• W3099857122 hasFunder F4320311272 @default.
• W3099857122 hasFunder F4320333908 @default.
• W3099857122 hasFunder F4320337351 @default.
• W3099857122 hasFunder F4320337361 @default.
• W3099857122 hasIssue "46" @default.
• W3099857122 hasLocation W30998571221 @default.

• next